Journal
JOURNAL OF BIOTECHNOLOGY
Volume 139, Issue 1, Pages 6-11Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jbiotec.2008.09.004
Keywords
PTTG1; PTTG1-binding factor; F-box; Targeted degradation; Growth inhibition
Categories
Funding
- National 863 Program [2007AA02Z16O]
Ask authors/readers for more resources
Pituitary tumor-transforming gene 1 (PTTG1), a proto-oncogene, is associated with tumor formation, proliferation and invasiveness. F-PBF beta-TrcP, a fusion protein, was produced by replacing the WD40-repeat of F-box protein beta-TrCP with the PTTG1-binding factor (PBF) for targeted degradation of PTTG1. To evaluate the function of F-PBF beta-TrcP, PTTG1-EGFP fusion protein was constructed. Our results showed that F-PBF beta-TrcP can both degrade exogenous PTTG1-EGFP fusion protein in COS-7 cells and endogenous PTTG1 protein in HeLa cells and the targeted PTTG1 knock down resulted in bFGF mRNA level down-regulation and inhibition of proliferation and clonogenicity in HeLa cells. In conclusion, targeted degradation of PTTG1 by F-PBF beta-TrcP has antitumor activity in vitro in HeLa cells. These results suggest that F-PBF beta-TrcP could be used for cancer treatment by targeted degradation of PTTG1. (c) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available